Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wachovia Capital Markets was the corporate and investment banking division of Wachovia Corporation, providing a broad suite of financial services including equity and debt underwriting, mergers and acquisitions advisory, and capital markets products. While the firm was a major player in the financial sector rather than a life sciences company, it maintained a dedicated healthcare investment banking group that advised biotechnology, pharmaceutical, and medical device companies. The firm played a significant role in financing the growth of various healthcare entities through IPOs and private placements during the early to mid-2000s. Following the financial crisis of 2008, Wachovia Corporation was acquired by Wells Fargo, and Wachovia Capital Markets was subsequently integrated into Wells Fargo Securities. Today, the legacy of its healthcare advisory business continues under the Wells Fargo brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wachovia Capital Markets.